Nancy Stuart
CIK 1594774 · Chief Operating Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CNCE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
55 CAMBRIDGE PARKWAY, SUITE 901E
LEXINGTON, MA 02421
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | Director | — | $27.00 | — | $0 | 6 | 2026-06-11 |
| CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Chief Operating Officer | 0 | $8.37 | $0 | -$2.19M | 31 | 2023-03-06 |
Recent Filings · Page 3 of 4
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-30 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Gift (G) | −1,850 | $0 | EDGAR |
| 2018-07-11 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Sell (S) | −31,418 | -$561.6K | EDGAR |
| 2018-04-13 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −4,418 | -$101.2K | EDGAR |
| 2018-04-03 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Tax (F) | −4,418 | -$101.2K | EDGAR |
| 2018-01-26 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | +37,816 | $14 | EDGAR |
| 2018-01-08 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-15 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | +2,076 | $10 | EDGAR |
| 2017-07-10 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Grant (A) | +60,000 | $0 | EDGAR |
| 2017-03-09 | CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted | Mixed | +1,951 | $13 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.